Nano-X Imaging Ltd. (NNOX)
| Market Cap | 270.03M |
| Revenue (ttm) | 12.30M |
| Net Income (ttm) | -55.71M |
| Shares Out | 65.38M |
| EPS (ttm) | -0.88 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,673,206 |
| Open | 4.235 |
| Previous Close | 4.360 |
| Day's Range | 3.970 - 4.280 |
| 52-Week Range | 2.780 - 11.000 |
| Beta | 1.08 |
| Analysts | Strong Buy |
| Price Target | 8.50 (+105.81%) |
| Earnings Date | Nov 20, 2025 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to ... [Read more]
Financial Performance
In 2024, Nano-X Imaging's revenue was $11.28 million, an increase of 13.91% compared to the previous year's $9.91 million. Losses were -$53.52 million, -11.95% less than in 2023.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for NNOX stock is "Strong Buy." The 12-month stock price target is $8.5, which is an increase of 105.81% from the latest price.
News
Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals
Nanox's HealthOST and HeathVCF recommended for use in UK National Health Service hospitals for a three-year period as the use of AI solutions in bone disease is evaluated
Nanox Announces $15 Million Registered Direct Offering of Common Stock
PETACH TIKVA, Israel, Nov. 23, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has enter...
Nano-X Imaging Ltd. (NNOX) Q3 2025 Earnings Call Transcript
Nano-X Imaging Ltd. ( NNOX) Q3 2025 Earnings Call November 20, 2025 8:30 AM EST Company Participants Mike Cavanaugh - IR-ICR Westwicke Erez Meltzer - CEO & Acting Chairman of the Board Ran Daniel - C...
Vaso Corporation Announces Divestiture of Subsidiary
Vaso Corporation 137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact: Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorpora...
Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions
PETACH TIKVA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that the parties ...
Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting
Live demonstrations of Nanox.ARC X to be featured at RSNA booth ( 3914, South Hall Level 3) every 30 minutes Innovation Theater p resentation to highlight development of pulmonary nodule AI solution, ...
Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging
Collaboration spans workers' compensation, nursing homes, and outpatient clinics PETACH TIKVA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), a...
Top 3 Health Care Stocks You'll Regret Missing This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Nano-X Imaging: Still No Opportunity Here
Nano-X Imaging Ltd.'s Q2 results missed expectations, with revenue, EPS, and adjusted EPS all falling short and losses widening year-over-year. Despite regulatory progress and some revenue growth, cor...
Nano-X Imaging Ltd. (NNOX) Q2 2025 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Erez I.
Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC
PETACH TIKVA, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a clinical and ed...
Nanox Imaging to Present at the Investor Summit Virtual on June 10, 2025
PETACH TIKVA, ISRAEL / ACCESS Newswire / June 9, 2025 / Nanox Imaging announced that Ran Daniel, Chief Financial Officer, will be presenting at the Investor Summit Virtual taking place on June 10. Abo...
Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
PETACH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-lea...
Nanox to Participate in Sidoti Small Cap Conference
PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will par...
Nano-X Imaging Ltd. (NNOX) Q1 2025 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2025 Earnings Conference Call May 22, 2025 8:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer and Acting C...
Nanox to Report First Quarter 2025 Financial Results on May 22, 2025
PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repor...
Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X
PETACH TIKVA, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has rece...
Nano-X Imaging Ltd. (NNOX) Q4 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer and Acting...
Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
ADOPT Study Findings Highlight Nanox.AI's Role in Enhancing Fracture Detection and Healthcare Cost Savings
Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will rep...
Nanox to Present New Clinical Data on Nanox.ARC Advanced 3D Digital Tomosynthesis Imaging System at ECR 2025
PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will pres...
Nano-X Imaging: When Will The Hockey Stick Growth Happen?
Nano-X Imaging is my speculative play for disruptive innovation in the biotech sector. With the S&P 500 at historical highs, lagging sectors like healthcare seem relatively attractive. The biotech sec...
Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication
PETACH TIKVA, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has recei...
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Mike Cavanaugh - IR Erez Meltzer - CEO Ran Daniel - CFO Conference Call Participan...